BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19758307)

  • 1. Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women.
    Ay C; Thom K; Abu-Hamdeh F; Horvath B; Quehenberger P; Male C; Mannhalter C; Pabinger I
    Haemophilia; 2010 Jan; 16(1):111-7. PubMed ID: 19758307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
    Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort.
    Morange PE; Tregouet DA; Frere C; Saut N; Pellegrina L; Alessi MC; Visvikis S; Tiret L; Juhan-Vague I
    Br J Haematol; 2005 Jan; 128(1):91-9. PubMed ID: 15606554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
    Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
    Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
    Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
    Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
    Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does FVIII-activity increase with age in patients with haemophilia A and carriers of haemophilia A?].
    Delbrück C; Haferland I; Scholz K; Asmelash G; Makki V; Müller S; Krekeler S; Alesci S; Miesbach W
    Hamostaseologie; 2011 Nov; 31 Suppl 1():S24-8. PubMed ID: 22057150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial clustering of factor VIII and von Willebrand factor levels.
    Kamphuisen PW; Houwing-Duistermaat JJ; van Houwelingen HC; Eikenboom JC; Bertina RM; Rosendaal FR
    Thromb Haemost; 1998 Feb; 79(2):323-7. PubMed ID: 9493584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.
    O'Donnell J; Tuddenham EG; Manning R; Kemball-Cook G; Johnson D; Laffan M
    Thromb Haemost; 1997 May; 77(5):825-8. PubMed ID: 9184386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sources of variation in factor VIII, von Willebrand factor and fibrinogen measurements: implications for detecting deficiencies and increased plasma levels.
    Bach J; Haubelt H; Hellstern P
    Thromb Res; 2010 Sep; 126(3):e188-95. PubMed ID: 20627205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
    Deitcher SR; Tuller J; Johnson JA
    Haemophilia; 1999 Mar; 5(2):88-95. PubMed ID: 10215955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.
    Wong CL; Szydlo R; Gibbs S; Laffan M
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):201-6. PubMed ID: 20182352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR; Rigsby P; Barrowcliffe TW
    Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilia A carrier detection by restriction fragment length polymorphism analysis and discriminant analysis based on ELISA of factor VIII and vWf.
    Poon MC; Hoar DI; Low S; Pon JK; Anand S; Sinclair GD
    J Lab Clin Med; 1992 Jun; 119(6):751-62. PubMed ID: 1350611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between phenotype and genotype in carriers of haemophilia A.
    Miesbach W; Alesci S; Geisen C; Oldenburg J
    Haemophilia; 2011 Mar; 17(2):246-51. PubMed ID: 21118332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques.
    Nesbitt IM; Goodeve AC; Guilliatt AM; Makris M; Preston FE; Peake IR
    Thromb Haemost; 1996 Jun; 75(6):959-64. PubMed ID: 8822593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
    Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
    Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.